Coherus BioSciences, Inc. (CHRS): Price and Financial Metrics
CHRS Price/Volume Stats
| Current price | $0.76 | 52-week high | $2.43 |
| Prev. close | $0.77 | 52-week low | $0.66 |
| Day low | $0.75 | Volume | 1,609,700 |
| Day high | $0.84 | Avg. volume | 1,940,129 |
| 50-day MA | $0.94 | Dividend yield | N/A |
| 200-day MA | $1.13 | Market Cap | 88.23M |
CHRS Stock Price Chart Interactive Chart >
Coherus BioSciences, Inc. (CHRS) Company Bio
Coherus Biosciences is a pure-play biosimilar platform company that develops and commercializes high-quality therapeutics for major regulated markets. The company was founded in 2010 and is based in Redwood City, California.
CHRS Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | -7.49% |
| 1-year | -64.15% |
| 3-year | -90.39% |
| 5-year | -95.48% |
| YTD | -44.93% |
| 2024 | -58.56% |
| 2023 | -57.95% |
| 2022 | -50.38% |
| 2021 | -8.17% |
| 2020 | -3.47% |
Continue Researching CHRS
Want to do more research on Coherus BioSciences Inc's stock and its price? Try the links below:Coherus BioSciences Inc (CHRS) Stock Price | Nasdaq
Coherus BioSciences Inc (CHRS) Stock Quote, History and News - Yahoo Finance
Coherus BioSciences Inc (CHRS) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...